Conversely and illustrative of the complexity of achieving homeostasis in regard to protein turnover and maintenance, proteasomal inhibition appears to ameliorate the decline in cardiac function in a hypertrophic cardiomyopathy model of mutated cMyBPC (Schlossarek et al., 2014b). Here, MYBPC3 is linked to hypertrophic cardiomyopathy.